New Key Statistics Module, Z-Score and F-Score
OTCPK:OBIMF Key Ratios
Market Cap $ M | 30.68 |
Enterprise Value $ M | 30.05 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 17.00 |
Price/Sales | 21.25 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.02 |
Beneish M-Score | -2.22 |
10-y EBITDA Growth Rate % | 9.20 |
5-y EBITDA Growth Rate % | -8.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.80 |
EV-to-EBITDA | -2.92 |
PEG | -- |
Shares Outstanding M | 278.24 |
Net Margin (%) | -873.24 |
Operating Margin % | -893.57 |
Pre-tax Margin (%) | -873.24 |
Quick Ratio | 0.48 |
Current Ratio | 0.80 |
ROA % (ttm) | -246.17 |
ROE % (ttm) | -670.11 |
ROIC % (ttm) | -491.02 |
Dividend Yield % | -- |
Altman Z-Score | -66.23 |
OBIMF Number of Guru Trades
OBIMF Volume of Guru Trades
Gurus Latest Trades with OTCPK:OBIMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OBIMF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ondine Biomedical Inc Insider Transactions
No Available Data
News about OTCPK:OBIMF
Total 0- 1